Article
The new generation hDHODH inhibitor MEDS433 hinders the <i>in vitro</i> replication of SARS-CoV-2
2020-12-07
Abstract excerpt
Identification and development of effective drugs active against SARS-CoV-2 are urgently needed. Here, we report on the anti-SARS-CoV-2 activity of MEDS433, a novel inhibitor of human dihydroorotate dehydrogenase (hDHODH), a key cellular enzyme of the de novo pyrimidines biosynthesis. MEDS433 inhibits in vitro virus replication in the low nanomolar range, and through a mechanism that stems from its ability to bl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a0f97b27-a83f-5b82-ab07-e8f73f31f86d
- DOI
- 10.1101/2020.12.06.412759
